Chitosan/beidellite (cas 12172-85-9) nanocomposite as diclofenac carrier

Add time:07/31/2019    Source:sciencedirect.com

Chitosan (CS) and purified sodium beidellite (Na-Bd) were used to obtain a nanocomposite able to carry anionic pharmaceutical ingredients. Diclofenac sodium (DS) was chosen as a model drug and was loaded by intercalation solution technique. Solid state characterization of the resultant hybrids was performed, including X-ray diffraction, Fourier transformed infrared spectroscopy, Thermal analysis and high resolution transmission electron microscopy coupled with energy dispersive X-Ray analysis. Drug loading capacity and encapsulation efficiency were quantified by measuring equilibrium concentration by UV–Vis spectroscopy at 276 nm. Solid-state characterization of the samples confirmed both chemical and physical interaction of DS with the nanocomposites. High drug loading along with a modified cumulative release of the drug in simulated intestinal fluid was obtained. The developed clay/polymer hybrids can act as potential candidates for the design of modified dosage forms of anionic drugs.

We also recommend Trading Suppliers and Manufacturers of beidellite (cas 12172-85-9). Pls Click Website Link as below: cas 12172-85-9 suppliers

Prev:Innovative unattended SEM-EDS analysis for asbestos fiber quantification
Next:Adsorption of terpenes from Eucalyptus globulus onto modified beidellite (cas 12172-85-9))